HARDIK GANDHI: Open Payments
NPI 1326493537 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 31 payments from 16 companies in 2025. Trend: 2023 $739 · 2024 $1,052 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $223 |
| SCPHARMACEUTICALS INC. | 2 | $129 |
| Lilly USA, LLC | 2 | $116 |
| Novartis Pharmaceuticals Corporation | 2 | $113 |
| Travere Therapeutics, Inc. | 1 | $109 |
| AKEBIA THERAPEUTICS INC | 2 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Apellis Pharmaceuticals, Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
Products named: TARPEYO, FUROSCIX, Vanrafia, Vafseo, Kerendia, JARDIANCE, Empaveli, TERLIVAZ.
Industry payments across MI — which companies pay providers there.
